Adam Mizgajski, MD
Hospitalist · Portland, ORNPI 1861428278
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 12 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 9 manufacturers, the largest accounting for just 22.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $570 and has fallen 89.3% since, to $61 in 2024. Among hospitalist clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 12 payments — averaging $86.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$230
- AstraZeneca$205
- Merck$125
- Boehringer Ingelheim$124
- Biohaven Pharmaceutical Holding Company Ltd.$121
- Pfizer$113
- plus $119 from 3 others
What the payments were for
- Food & beverage$1,037100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $230 |
| AstraZeneca | 2 | $205 |
| Merck | 1 | $125 |
| Boehringer Ingelheim | 1 | $124 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $121 |
| Pfizer | 1 | $113 |
| Abiomed | 1 | $61 |
| Novartis | 2 | $38 |
| AbbVie | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AJOVY$230
- ZERBAXA$125
- FARXIGA$122
- NURTEC ODT$121
- COLOGUARD$113
How this compares
$1,037 in reported general payments places this provider in the 95th percentile of 395 hospitalist providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metoprolol Succinate | 18 | $196 |
| Torsemide | 11 | $118 |
| Atorvastatin Calcium | 11 | $109 |
| Spironolactone | 11 | $91 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Portland
- Renee DversdalPortland$25K
- Lauren CooperPortland$10K
- James AnsteyPortland$5K
- Vinay SiddappaPortland$5K
- Lindee StrizichPortland$5K
- Andre MansoorPortland$3K
- Kathleen MoffittPortland$3K
- Bassel BeitinjanehPortland$3K
- Victor PhamPortland$2K
- Bindesh GhimirePortland$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.